32
Participants
Start Date
July 31, 2018
Primary Completion Date
August 30, 2019
Study Completion Date
December 5, 2019
DDAVP Inhalant Product
For the DDAVP intervention the participant will take either 1 or 2 nasal sprays of IN DDAVP. After receiving IN DDAVP, the participant will rest for 30 minutes.
Exercise Intervention
For the exercise intervention the participant will exercise on a stationary cycle-ergometer using the previously-validated, progressively-incremental Godfrey protocol. Per the Godfrey protocol, the participant starts cycling on the calibrated cycle-ergometer with an initial exercise load that is dependent on their height. The workload is increased every minute in standard increments also based on the participant's height. All participants will exercise till they complete 3-minutes of cycling at 85% of their maximum predicted heart rate or till exhaustion (whichever comes first). Upon completion of planned exercise, work load will be decreased to zero watts and participants will be instructed to continue cycling at this cool-down rate for additional 3-minutes, before getting of the ergometer.
Nationwide Children's Hospital, Columbus
Akron Children's Hospital, Akron
Dayton Children's Hospital, Dayton
Indiana Hemophilia and Thrombosis Center, Indianapolis
The Hospital for Sick Children
OTHER
Nationwide Children's Hospital
OTHER